Epistaxis

Anterior Epistaxis Nasal Pack

Posterior Epistaxis Nasal Pack

Epistaxis: Topische Anwendung von Tranxexamsäure: 0,5 vs. 1g

PACKING: Use of tranexamic acid-soaked NasoPore® in the emergency department, to reduce epistaxis admissions

Efficacy of topical tranexamic acid in epistaxis: A systematic review and meta-analysis

Recurrent epistaxis in children

Von Willebrand Disease: Current Status of Diagnosis and Management

The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial

Case Report: Massive epistaxis from juvenile angiofibroma in an adolescent with severe haemophilia A

Effect of Intranasal Vasoconstrictors on Blood Pressure: A Randomized, Double-Blind, Placebo-Controlled Trial

Clinical Practice Guideline: Nosebleed (Epistaxis)

Soforttherapie / Kompression / Packing

... nosebleed was the presenting symptom in 31% of patients with this disorder and that 56% of these patients have had nosebleeds at some point.

... identified nosebleeds as one of the most common bleeding symptoms, with 5% of patients with immune thrombocytopenia having a nosebleed.

Anticoagulant and antiplatelet medications increase the risk of nosebleeds.

Oxymetazolin (z.B. NASIVIN)

Adrenalin (1: 100.000) = 10 µg pro ml

fdfdsf